Areej Aljehani

ORCID: 0009-0005-5502-3618
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Effects of Exercise
  • Sports injuries and prevention
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Hormonal and reproductive studies
  • Cardiac Structural Anomalies and Repair
  • Cardiac pacing and defibrillation studies
  • Bone health and osteoporosis research
  • Bone and Joint Diseases
  • Cardiac electrophysiology and arrhythmias
  • Bone health and treatments

University of Birmingham
2022-2024

King Saud bin Abdulaziz University for Health Sciences
2023-2024

University Hospitals Birmingham NHS Foundation Trust
2023-2024

National Guard Health Affairs
2024

Androgenic anabolic steroids (AAS) are commonly abused by young men. Male sex and increased AAS levels associated with earlier more severe manifestation of common cardiac conditions, such as atrial fibrillation, rare ones, arrhythmogenic right ventricular cardiomyopathy (ARVC). Clinical observations suggest a potential involvement in ARVC. Arrhythmogenic is caused desmosomal gene defects, including reduced plakoglobin expression. Here, we analysed clinical records from 146 ARVC patients to...

10.1113/jp284597 article EN cc-by The Journal of Physiology 2024-02-12

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare inherited disease characterised by early arrhythmias and structural changes. Still, there are limited echocardiography data on its progression. We studied progression impact the occurrence of major adverse cardiovascular events (MACE). In this single-centre observational cohort study, was defined as development new or minor imaging 2010 Task Force Criteria during follow-up. Of 101 patients, definite diagnosis ARVC made in 51...

10.3390/biomedicines12020328 article EN cc-by Biomedicines 2024-01-31

Abstract Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic is a rare inherited disease with incomplete penetrance and an environmental component. Although disease, ARVC common cause of sudden cardiac death in young adults. Data on the different stages remains scarce. The purpose this study to describe initial presentation phenotype definite non-definite for patients seen at tertiary service. Methods This single centre, observational cohort Inherited Cardiac...

10.1186/s12872-022-03021-w article EN cc-by BMC Cardiovascular Disorders 2023-01-12

Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder associated with an elevated risk of life-threatening arrhythmias and progressive impairment. Risk stratification essential to prevent major adverse cardiac events (MACE). Our study aimed investigate the incremental value strain measured by two-dimensional speckle-tracking echocardiography in predicting MACE ARVC patients compared conventional echocardiographic parameters. Methods Results This was...

10.3390/jcdd11120388 article EN cc-by Journal of Cardiovascular Development and Disease 2024-12-03

Abstract Atypical femoral fractures (AFF) are rare stress with specific diagnostic criteria, as outlined in a report published by the American Society for Bone and Mineral Research. These criteria categorized into major minor features, AFF can be classified either complete or incomplete. Bisphosphonates have been shown to increase risk of AFF, most cases associated bisphosphonate use. We present unique case young woman no history She was taking oral contraceptive pills inhaled...

10.1093/jscr/rjaf020 article EN cc-by Journal of Surgical Case Reports 2024-12-21

<h3>Background</h3> In patients with Arrhythmogenic right ventricular cardiomyopathy (ARVC, also called "Arrhythmogenic Cardiomyopathy"), it is a challenge to predict those at greatest risk of major adverse cardiac events (MACE). Our hypothesis that arrhythmia may be preceded by change in structure and function. <h3>Purpose</h3> To assess the association between function over time (MACE) ARVC. <h3>Methods</h3> 101 definite non-definite ARVC (defined as per Revised task force criteria (TFC))...

10.1136/heartjnl-2023-bcs.173 article EN cc-by-nc Imaging 2023-06-01

Abstract Background In patients with Arrhythmogenic right ventricular cardiomyopathy (ARVC, also called"Arrhythmogenic Cardiomyopathy"), it is a challenge to predict those at greatest risk of major adverse cardiac events (MACE). Our hypothesis that arrhythmia may be preceded by change in structure and function. Purpose To assess the association between function over time (MACE) ARVC. Methods 101 definite non-definite ARVC (defined as per Revised Task Force criteria (TFC)) were included least...

10.1093/eurheartj/ehad655.053 article EN European Heart Journal 2023-11-01

Abstract Androgenic anabolic steroids (AAS) are commonly abused by young men. Male sex associates with earlier manifestation of common and rare cardiac conditions including atrial fibrillation arrhythmogenic right ventricular cardiomyopathy (ARVC). Clinical data suggest an involvement in ARVC. The disease is caused desmosomal gene defects such as reduced plakoglobin expression. Analysis clinical records from 146 ARVC patients identified male preponderance increased prevalence arrhythmias...

10.1101/2022.06.03.494748 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-06-04

Abstract BackgroundArrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic is a rare inherited disease with incomplete penetrance and an environmental component. As ARVC common cause of sudden cardiac death in young adults, which can be the first symptom, recognition early important. Data on different stages remains scarce. The purpose this study to describe initial presentation phenotype definite for patients seen at tertiary service.MethodsThis single centre, observational...

10.21203/rs.3.rs-1804660/v1 preprint EN cc-by Research Square (Research Square) 2022-07-25
Coming Soon ...